When activated with GLP-1r, GIP seems to potentiate not only the weight loss mechanism of the incretin but also the glucose lowering effects [13]
KCCM, Korean Culture Center of Microorganisms, South Korea
Candidates should also: Be non-smokers, or willing to quit prior to beginning treatment Live a healthy lifestyle, including an exercise program and a healthy diet Understand the risks of the treatment Have a positive outlook and realistic goals Be prepared to closely follow instructions Cannot have a history of thyroid cancer or Multiple Endocrine Neoplasia (MEN) syndrome Cannot have a history of intestinal obstruction It is important to note that compounded GLP-1 Therapy treatments are just a portion of a successful weight loss program
Fiorentino A, D'Abrosca B, Pacifico S, Golino A, Mastellone C, Oriano P, Monaco P
Neurochemical Research .Read source (2022)
When a compound has no completed human trial, there is by definition no safety data in any subgroup no pregnancy data, no hepatic-impairment data, no interaction data with common metabolic or endocrine medications